BRPI0318594B8 - proteína recombinante que possui um efeito anticâncer, seu gene de codificação, seu uso, medicamento para tratar cânceres, vetor de expressão e microrganismo transgênico - Google Patents
proteína recombinante que possui um efeito anticâncer, seu gene de codificação, seu uso, medicamento para tratar cânceres, vetor de expressão e microrganismo transgênicoInfo
- Publication number
- BRPI0318594B8 BRPI0318594B8 BRPI0318594A BR0318594A BRPI0318594B8 BR PI0318594 B8 BRPI0318594 B8 BR PI0318594B8 BR PI0318594 A BRPI0318594 A BR PI0318594A BR 0318594 A BR0318594 A BR 0318594A BR PI0318594 B8 BRPI0318594 B8 BR PI0318594B8
- Authority
- BR
- Brazil
- Prior art keywords
- seq
- amino acid
- recombinant protein
- protein
- same activity
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 4
- 230000001093 anti-cancer Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 230000009261 transgenic effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- 238000007792 addition Methods 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2003/000928 WO2005042744A1 (en) | 2003-11-03 | 2003-11-03 | A recombinant protein with cancer suppression action, its encoding gene and use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0318594A BR0318594A (pt) | 2006-10-17 |
| BRPI0318594B1 BRPI0318594B1 (pt) | 2017-12-26 |
| BRPI0318594B8 true BRPI0318594B8 (pt) | 2021-05-25 |
Family
ID=34529378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0318594A BRPI0318594B8 (pt) | 2003-11-03 | 2003-11-03 | proteína recombinante que possui um efeito anticâncer, seu gene de codificação, seu uso, medicamento para tratar cânceres, vetor de expressão e microrganismo transgênico |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7666989B2 (enExample) |
| EP (1) | EP1688498B1 (enExample) |
| JP (1) | JP4688678B2 (enExample) |
| CN (1) | CN100549175C (enExample) |
| AT (1) | ATE501256T1 (enExample) |
| AU (1) | AU2003280921B2 (enExample) |
| BR (1) | BRPI0318594B8 (enExample) |
| CA (1) | CA2544473C (enExample) |
| DE (1) | DE60336353D1 (enExample) |
| NZ (1) | NZ547274A (enExample) |
| WO (1) | WO2005042744A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1761680A (zh) | 2002-12-26 | 2006-04-19 | 武田药品工业株式会社 | 肿瘤迁移抑制素衍生物及其用途 |
| PE20060371A1 (es) | 2004-06-25 | 2006-06-15 | Takeda Pharmaceutical | Derivados de metastina en el tratamiento del cancer |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| AR058584A1 (es) | 2005-12-22 | 2008-02-13 | Takeda Pharmaceutical | Derivados de metastina y uso de los mismos |
| JO3048B1 (ar) | 2006-10-25 | 2016-09-05 | Takeda Pharmaceuticals Co | مشتقات متاستين واستخدامها |
| EP2277900A4 (en) * | 2008-04-24 | 2011-08-03 | Takeda Pharmaceutical | METASTINE DERIVATIVE AND ITS USE |
| HUE027068T2 (en) | 2010-12-03 | 2016-08-29 | Adamed Sp Zoo | Anticancer fusion protein |
| PL219845B1 (pl) | 2011-01-05 | 2015-07-31 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
| PL394618A1 (pl) | 2011-04-19 | 2012-10-22 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
| US9289468B2 (en) | 2011-09-16 | 2016-03-22 | Beijing Sunbio Biotech Co. Ltd. | Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof |
| PL397167A1 (pl) | 2011-11-28 | 2013-06-10 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
| PL223487B1 (pl) | 2011-12-28 | 2016-10-31 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100510234B1 (ko) * | 1995-06-29 | 2005-11-25 | 임뮤넥스 코포레이션 | 세포소멸을 유도하는 시토킨 |
| US6284236B1 (en) * | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
| KR20010019100A (ko) | 1999-08-25 | 2001-03-15 | 황규언 | 인간 유래 세포소멸인자 ｔｒａｉｌ의 결정화에 의한 3차원 구조 |
| US6900185B1 (en) | 2000-04-12 | 2005-05-31 | University Of Iowa Research Foundation | Method of inducing tumor cell apoptosis using trail/Apo-2 ligand gene transfer |
| KR100436089B1 (ko) | 2000-07-06 | 2004-06-14 | 설대우 | 분비성 재조합 트라이머형의 트레일 단백질 생산을 위한 디엔에이 카세트, 테트라사이클린/독시사이클린-유도성아데노-관련 바이러스 벡터, 이 둘의 조합, 및 이들을이용한 유전자 치료 |
| CN1205335C (zh) * | 2001-11-30 | 2005-06-08 | 中国人民解放军第二军医大学 | 肿瘤凋亡诱导配体基因、基因表达蛋白及其制备方法 |
-
2003
- 2003-11-03 EP EP03770858A patent/EP1688498B1/en not_active Expired - Lifetime
- 2003-11-03 WO PCT/CN2003/000928 patent/WO2005042744A1/zh not_active Ceased
- 2003-11-03 US US10/577,535 patent/US7666989B2/en not_active Expired - Lifetime
- 2003-11-03 CA CA2544473A patent/CA2544473C/en not_active Expired - Lifetime
- 2003-11-03 CN CNB2003801106041A patent/CN100549175C/zh not_active Expired - Lifetime
- 2003-11-03 AT AT03770858T patent/ATE501256T1/de not_active IP Right Cessation
- 2003-11-03 DE DE60336353T patent/DE60336353D1/de not_active Expired - Lifetime
- 2003-11-03 JP JP2005510086A patent/JP4688678B2/ja not_active Expired - Lifetime
- 2003-11-03 NZ NZ547274A patent/NZ547274A/en not_active IP Right Cessation
- 2003-11-03 BR BRPI0318594A patent/BRPI0318594B8/pt not_active IP Right Cessation
- 2003-11-03 AU AU2003280921A patent/AU2003280921B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA2544473A1 (en) | 2005-05-12 |
| ATE501256T1 (de) | 2011-03-15 |
| EP1688498A4 (en) | 2007-06-20 |
| WO2005042744A1 (en) | 2005-05-12 |
| BRPI0318594B1 (pt) | 2017-12-26 |
| DE60336353D1 (de) | 2011-04-21 |
| AU2003280921B2 (en) | 2007-09-13 |
| EP1688498B1 (en) | 2011-03-09 |
| EP1688498A1 (en) | 2006-08-09 |
| AU2003280921A1 (en) | 2005-05-19 |
| CA2544473C (en) | 2013-08-13 |
| HK1089788A1 (zh) | 2006-12-08 |
| CN1860229A (zh) | 2006-11-08 |
| US20080280821A1 (en) | 2008-11-13 |
| NZ547274A (en) | 2009-02-28 |
| US7666989B2 (en) | 2010-02-23 |
| CN100549175C (zh) | 2009-10-14 |
| JP4688678B2 (ja) | 2011-05-25 |
| BR0318594A (pt) | 2006-10-17 |
| JP2007536891A (ja) | 2007-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA521430398B1 (ar) | Ph20 تركيبة صيدلانية، تشمل متغير ودواء هيالورونيداز البشرى، للحقن تحت الجلد | |
| DE60327786D1 (de) | Kdr-peptide und diese enthaltende impfstoffe | |
| BRPI0318594B8 (pt) | proteína recombinante que possui um efeito anticâncer, seu gene de codificação, seu uso, medicamento para tratar cânceres, vetor de expressão e microrganismo transgênico | |
| JP2005506035A5 (enExample) | ||
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| BR0214302A (pt) | Polipeptìdeo que tem atividade antimicrobiana, polinucleotìdeo, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, método para produzir um polipeptìdeo comosição antimicrobiana, método para matar ou inibir o crescimento de células microbianas, composição detergente, uso de um polipeptìdeo antimicrobiano planta transgênica, parte da planta ou célula da planta, aditivo para ração animal, composição de ração animal | |
| MX2009008270A (es) | Polipeptido novedoso que tiene actividad anti-tumoral. | |
| Sarkar et al. | The curious case of SARM1: Dr. Jekyll and Mr. Hyde in cell death and immunity? | |
| BR0209551A (pt) | Promotor de gene especìfico de folha de café | |
| BR112021025948A2 (pt) | Polipeptídeos antimicrobianos derivados de bacteriófagos e seu uso contra bactérias gram-negativas e ácido-resistentes | |
| NZ755599A (en) | Apoc-ii mimetic peptides | |
| Lynch et al. | 'De-evolution'of Drosophila toward a more generic mode of axis patterning. | |
| RU2006119452A (ru) | Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение | |
| DE60128445D1 (de) | Mutiertes cyclin g1 protein | |
| CO6160332A2 (es) | Agente para terapia y/o mejoramiento de coagulacion intravascular diseminada | |
| AR013801A1 (es) | Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la | |
| MX2023006153A (es) | Terapias genicas para enfermedad neurodegenerativa. | |
| BRPI0415296A (pt) | cdna modificado para os nìveis de expressão elevados do fator viii e seus derivados | |
| JP2006504403A5 (enExample) | ||
| JP4686780B2 (ja) | 細胞死抑制活性強化タンパク質ｆｎｋを用いた脱毛の防止 | |
| NZ505350A (en) | DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours | |
| WO2000047607B1 (en) | A synthetic peptide disturbing intracellular signaling | |
| Lieb | A new metallothionein gene from the giant keyhole limpet Megathura crenulata | |
| DE602005025989D1 (de) | Von 2',3'-didesoxynucleosiden und 2',3'-didehydro-2',3'-didesoxynucleosiden | |
| CA2498651A1 (en) | Nucleoside triphosphate diphosphohydrolase and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/12/2017, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/11/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2799 DE 27-08-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |